196 related articles for article (PubMed ID: 36263706)
41. Thiosemicarbazone N-Heterocyclic Cu(II) complexes inducing nuclei DNA and mitochondria damage in hepatocellular carcinoma cells.
Zhang S; Zhao J; Guo Y; Hu J; Chen X; Ruan H; Cao T; Hou H
J Inorg Biochem; 2022 Nov; 236():111964. PubMed ID: 36027842
[TBL] [Abstract][Full Text] [Related]
42. Study on potential antitumor mechanism of a novel Schiff base copper(II) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity.
Qiao X; Ma ZY; Xie CZ; Xue F; Zhang YW; Xu JY; Qiang ZY; Lou JS; Chen GJ; Yan SP
J Inorg Biochem; 2011 May; 105(5):728-37. PubMed ID: 21463568
[TBL] [Abstract][Full Text] [Related]
43. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
44. Functional copper complexes with benzofurans tridentate ligand: Synthesis, crystal structure, DNA binding and anticancer studies.
Chen YM; Liu YC; Wang JQ; Ou GC; Wang XF; Gao SQ; Du KJ; Lin YW
J Inorg Biochem; 2023 Oct; 247():112330. PubMed ID: 37478782
[TBL] [Abstract][Full Text] [Related]
45. Antiproliferative activity of platinum(II) and copper(II) complexes containing novel biquinoxaline ligands.
El-Beshti HS; Gercek Z; Kayi H; Yildizhan Y; Cetin Y; Adigüzel Z; Güngör G; Özalp-Yaman Ş
Metallomics; 2024 Feb; 16(2):. PubMed ID: 38183277
[TBL] [Abstract][Full Text] [Related]
46. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
47. Spectroscopic, Computational, Antimicrobial, DNA Interaction, In Vitro Anticancer and Molecular Docking Properties of Biochemically Active Cu(II) and Zn(II) Complexes of Pyrimidine-Ligand.
Sankarganesh M; Dhaveethu Raja J; Adwin Jose PR; Vinoth Kumar GG; Rajesh J; Rajasekaran R
J Fluoresc; 2018 Jul; 28(4):975-985. PubMed ID: 29961205
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with norcantharidin and benzimidazole derivatives.
Song WJ; Lin QY; Jiang WJ; Du FY; Qi QY; Wei Q
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():122-8. PubMed ID: 25218220
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, crystal structure, spectroscopic properties and potential biological activities of salicylate‒neocuproine ternary copper(II) complexes.
Kucková L; Jomová K; Švorcová A; Valko M; Segľa P; Moncoľ J; Kožíšek J
Molecules; 2015 Jan; 20(2):2115-37. PubMed ID: 25633337
[TBL] [Abstract][Full Text] [Related]
50. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, crystal structures, anticancer activities and molecular docking studies of novel thiazolidinone Cu(II) and Fe(III) complexes targeting lysosomes: special emphasis on their binding to DNA/BSA.
Shao J; Zhang Q; Wei J; Yuchi Z; Cao P; Li SQ; Wang S; Xu JY; Yang S; Zhang Y; Wei JX; Tian JL
Dalton Trans; 2021 Oct; 50(38):13387-13398. PubMed ID: 34473154
[TBL] [Abstract][Full Text] [Related]
54. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.
Annaraj B; Balakrishnan C; Neelakantan MA
J Photochem Photobiol B; 2016 Jul; 160():278-91. PubMed ID: 27155593
[TBL] [Abstract][Full Text] [Related]
56. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
[TBL] [Abstract][Full Text] [Related]
57. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
Deng J; Gou Y; Chen W; Fu X; Deng H
Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
[TBL] [Abstract][Full Text] [Related]
58. Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cells.
Yousuf I; Arjmand F; Tabassum S; Toupet L; Khan RA; Siddiqui MA
Dalton Trans; 2015 Jun; 44(22):10330-42. PubMed ID: 25970097
[TBL] [Abstract][Full Text] [Related]
59. Photocytotoxic copper(II) complexes of N-salicylyl-l-tryptophan and phenanthroline bases.
Banaspati A; Das D; Choudhury CJ; Bhattacharyya A; Goswami TK
J Inorg Biochem; 2019 Feb; 191():60-68. PubMed ID: 30468943
[TBL] [Abstract][Full Text] [Related]
60. Bis(triazinyl)pyridine complexes of Pt(II) and Pd(II): studies of the nucleophilic substitution reactions, DNA/HSA interactions, molecular docking and biological activity.
Jovanović-Stević S; Radisavljević S; Scheurer A; Ćoćić D; Šmit B; Petković M; Živanović MN; Virijević K; Petrović B
J Biol Inorg Chem; 2021 Aug; 26(5):625-637. PubMed ID: 34268603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
